Ampersand, digital health therapies provider for inflammatory conditions, has partnered with Simplyhealth and received investment from the health solutions company, to increase the roll out of digital therapeutics across the UK.
The investment by Simplyhealth aims to help reduce outpatient appointments, improve health outcomes, and reduce unplanned hospital visits for patients suffering with inflammatory conditions. Ampersand provides digital health tools for clinicians and patients to better manage and monitor chronic, inflammatory diseases which includes Crohn's, arthritis and psoriasis. The provider works in conjunction with scientists, clinicians, and NHS Trusts, to implement behavioural science-based inter...
To continue reading this article...
Join Cover
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
